The Dow Chemical Company has signed a definitive agreement to purchase The Collaborative Group’s Biotechnology Services Division, including all of the assets of Collaborative BioAlliance, Inc. (CBA) and Collaborative Smithfield Corp. Pending regulatory review and obtaining certain third-party consents, the acquisition is expected to close towards the end of November. The financial terms of the Read more about Dow To Acquire Collaborative BioAlliance[…]